Tilak Mandadi - 01 Apr 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP, Chief Technology Officer
Signature: /s/ Tilak Mandadi
Issuer symbol: CVS
Transactions as of: 01 Apr 2024
Net transactions value: +$5,403,715
Form type: 4
Filing time: 03 Apr 2024, 16:49:57 UTC
Previous filing: 01 Sep 2023
Next filing: 03 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (RSU)	Award	$0	+16,339	+25%	$0.000000	82,904	01 Apr 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$5,403,715	+67,920		$79.56	67,920	01 Apr 2024	Common Stock	67,920	$79.56	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.
F2	Option becomes exercisable in four equal annual installments, commencing 4/1/2025.